Skip to main content
Erschienen in: Journal of Gastroenterology 4/2014

01.04.2014 | Original Article—Liver, Pancreas, and Biliary Tract

Kir6.2 knockout aggravates lipopolysaccharide-induced mouse liver injury via enhancing NLRP3 inflammasome activation

verfasst von: Ren-Hong Du, Jun Tan, Nan Yan, Ling Wang, Chen Qiao, Jian-Hua Ding, Ming Lu, Gang Hu

Erschienen in: Journal of Gastroenterology | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

ATP-sensitive potassium (K-ATP) channels couple cellular metabolism to electric activity. Although Kir6.2-composed K-ATP channel (Kir6.2/K-ATP channel) has been demonstrated to regulate inflammation, a common cause of most liver diseases, its role in liver injury remains elusive.

Methods

Kir6.2 knockout mice were used to prepared LPS-induced liver injury model so as to investigate the role of Kir6.2/K-ATP channels in the injury. Histochemistry was applied to evaluate the extent of liver injury. Proinflammatory cytokines were analyzed by ELISA. Endoplasmic reticulum (ER) stress and autophagy were assessed by western blotting.

Results

We showed that Kir6.2 knockout markedly promoted the infiltration of lymphocytes and neutrophils in liver and significantly elevated serum levels of alanine transaminase (ALT) in respond to LPS treatment. We further found that Kir6.2 deficiency enhanced the activation of NF-κB and NLRP3 inflammasome following LPS challenge, and thereby increased the levels of pro-inflammatory cytokines IL-1β, IL-18 and TNF-α. Treatment of wild-type mice with the K-ATP channel opener iptakalim (IPT) could protect against LPS-induced liver injury through attenuating NLRP3 inflammasome-mediated inflammatory responses. Furthermore, Kir6.2 knockout-induced activation of NLRP3 inflammasome aggravated endoplasmic reticulum (ER) stress, autophagy and subsequent hepatocyte death.

Conclusion

Kir6.2 deficiency exacerbated LPS-induced liver injury by enhancing NLRP3 inflammasome-mediated inflammatory response. Thus, Kir6.2/K-ATP channel may be a potential candidate target for the treatment and prevention of liver injury.
Literatur
1.
Zurück zum Zitat Morrell MR, Micek ST, Kollef MH. The management of severe sepsis and septic shock. Infect Dis Clin North Am. 2009;23:485–501.PubMedCrossRef Morrell MR, Micek ST, Kollef MH. The management of severe sepsis and septic shock. Infect Dis Clin North Am. 2009;23:485–501.PubMedCrossRef
2.
Zurück zum Zitat Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin Liver Dis. 2009;29:166–77.PubMedCrossRef Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin Liver Dis. 2009;29:166–77.PubMedCrossRef
3.
Zurück zum Zitat Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res. 2003;9:293–300.PubMedCrossRef Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res. 2003;9:293–300.PubMedCrossRef
4.
Zurück zum Zitat Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology. 2009;136:1476–83.PubMedCrossRef Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology. 2009;136:1476–83.PubMedCrossRef
5.
Zurück zum Zitat Dare AJ, Phillips AR, Hickey AJ, Mittal A, Loveday B, Thompson N, et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radical Biol Med. 2009;47:1517–25.CrossRef Dare AJ, Phillips AR, Hickey AJ, Mittal A, Loveday B, Thompson N, et al. A systematic review of experimental treatments for mitochondrial dysfunction in sepsis and multiple organ dysfunction syndrome. Free Radical Biol Med. 2009;47:1517–25.CrossRef
7.
Zurück zum Zitat Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179–85.PubMedCentralPubMed Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482:179–85.PubMedCentralPubMed
8.
Zurück zum Zitat Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol. 1995;146:1220–34.PubMedCentralPubMed Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol. 1995;146:1220–34.PubMedCentralPubMed
9.
Zurück zum Zitat Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, et al. Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol. 2009;296:G1248–57.CrossRef Watanabe A, Sohail MA, Gomes DA, Hashmi A, Nagata J, Sutterwala FS, et al. Inflammasome-mediated regulation of hepatic stellate cells. Am J Physiol. 2009;296:G1248–57.CrossRef
11.
Zurück zum Zitat Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10:241–7.PubMedCentralPubMedCrossRef Franchi L, Eigenbrod T, Munoz-Planillo R, Nunez G. The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis. Nat Immunol. 2009;10:241–7.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Imamura M, Tsutsui H, Yasuda K, Uchiyama R, Yumikura-Futatsugi S, Mitani K, et al. Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol. 2009;51:333–41.PubMedCrossRef Imamura M, Tsutsui H, Yasuda K, Uchiyama R, Yumikura-Futatsugi S, Mitani K, et al. Contribution of TIR domain-containing adapter inducing IFN-beta-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol. 2009;51:333–41.PubMedCrossRef
14.
Zurück zum Zitat Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Investig. 2012;122:3476–89.PubMedCentralPubMedCrossRef Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Investig. 2012;122:3476–89.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Hoque R, Vodovotz Y, Mehal W. Therapeutic strategies in inflammasome mediated diseases of the liver. J Hepatol. 2013;58:1047–52.PubMedCrossRef Hoque R, Vodovotz Y, Mehal W. Therapeutic strategies in inflammasome mediated diseases of the liver. J Hepatol. 2013;58:1047–52.PubMedCrossRef
16.
Zurück zum Zitat Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K + channels. Prog Biophys Mol Biol. 2003;81:133–76.PubMedCrossRef Seino S, Miki T. Physiological and pathophysiological roles of ATP-sensitive K + channels. Prog Biophys Mol Biol. 2003;81:133–76.PubMedCrossRef
17.
Zurück zum Zitat Yokoshiki H, Sunagawa M, Seki T, Sperelakis N. ATP-sensitive K + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol. 1998;274:C25–37.PubMed Yokoshiki H, Sunagawa M, Seki T, Sperelakis N. ATP-sensitive K + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol. 1998;274:C25–37.PubMed
18.
Zurück zum Zitat Sikka P, Kapoor S, Bindra VK, Saini M, Saxena KK. Iptakalim: a novel multi-utility potassium channel opener. J Pharmacol Pharmacother. 2012;3:12–4.PubMedCentralPubMedCrossRef Sikka P, Kapoor S, Bindra VK, Saini M, Saxena KK. Iptakalim: a novel multi-utility potassium channel opener. J Pharmacol Pharmacother. 2012;3:12–4.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Buckley JF, Singer M, Clapp LH. Role of KATP channels in sepsis. Cardiovasc Res. 2006;72:220–30.PubMedCrossRef Buckley JF, Singer M, Clapp LH. Role of KATP channels in sepsis. Cardiovasc Res. 2006;72:220–30.PubMedCrossRef
20.
Zurück zum Zitat Hai S, Takemura S, Minamiyama Y, Yamasaki K, Yamamoto S, Kodai S, et al. Mitochondrial K(ATP) channel opener prevents ischemia–reperfusion injury in rat liver. Transplant Proc. 2005;37:428–31.PubMedCrossRef Hai S, Takemura S, Minamiyama Y, Yamasaki K, Yamamoto S, Kodai S, et al. Mitochondrial K(ATP) channel opener prevents ischemia–reperfusion injury in rat liver. Transplant Proc. 2005;37:428–31.PubMedCrossRef
21.
Zurück zum Zitat Zhou F, Yao HH, Wu JY, Ding JH, Sun T, Hu G. Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation. J Cell Mol Med. 2008;12:1559–70.PubMedCrossRef Zhou F, Yao HH, Wu JY, Ding JH, Sun T, Hu G. Opening of microglial K(ATP) channels inhibits rotenone-induced neuroinflammation. J Cell Mol Med. 2008;12:1559–70.PubMedCrossRef
22.
Zurück zum Zitat Plachinta RV, de Klaver MJ, Hayes JK, Rich GF. The protective effect of protein kinase C and adenosine triphosphate-sensitive potassium channel agonists against inflammation in rat endothelium and vascular smooth muscle in vitro and in vivo. Anesth Analg. 2004;99:556–61.PubMedCrossRef Plachinta RV, de Klaver MJ, Hayes JK, Rich GF. The protective effect of protein kinase C and adenosine triphosphate-sensitive potassium channel agonists against inflammation in rat endothelium and vascular smooth muscle in vitro and in vivo. Anesth Analg. 2004;99:556–61.PubMedCrossRef
23.
Zurück zum Zitat Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci USA. 1998;95:10402–6.PubMedCentralPubMedCrossRef Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci USA. 1998;95:10402–6.PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139(323–34):e7.PubMed Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 2010;139(323–34):e7.PubMed
25.
Zurück zum Zitat Eijo G, Zarate S, Jaita G, Ferraris J, Magri ML, Zaldivar V, et al. Inhibition of nuclear factor-kappa B sensitises anterior pituitary cells to tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptosis. J Neuroendocrinol. 2011;23:651–9.PubMedCrossRef Eijo G, Zarate S, Jaita G, Ferraris J, Magri ML, Zaldivar V, et al. Inhibition of nuclear factor-kappa B sensitises anterior pituitary cells to tumour necrosis factor-alpha- and lipopolysaccharide-induced apoptosis. J Neuroendocrinol. 2011;23:651–9.PubMedCrossRef
26.
Zurück zum Zitat Ganz M, Csak T, Nath B, Szabo G. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J Gastroenterol. 2011;17:4772–8.PubMedCentralPubMedCrossRef Ganz M, Csak T, Nath B, Szabo G. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J Gastroenterol. 2011;17:4772–8.PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Tsutsui H, Imamura M, Fujimoto J, Nakanishi K. The TLR4/TRIF-mediated activation of nlrp3 inflammasome underlies endotoxin-induced liver injury in mice. Gastroenterol Res Pract. 2010;2010:641865.PubMedCentralPubMedCrossRef Tsutsui H, Imamura M, Fujimoto J, Nakanishi K. The TLR4/TRIF-mediated activation of nlrp3 inflammasome underlies endotoxin-induced liver injury in mice. Gastroenterol Res Pract. 2010;2010:641865.PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Rautou PE, Cazals-Hatem D, Moreau R, Francoz C, Feldmann G, Lebrec D, et al. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology. 2008;135:840–8, 8 e1–3. Rautou PE, Cazals-Hatem D, Moreau R, Francoz C, Feldmann G, Lebrec D, et al. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology. 2008;135:840–8, 8 e1–3.
29.
Zurück zum Zitat Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 2011;54:133–44.PubMedCrossRef Csak T, Ganz M, Pespisa J, Kodys K, Dolganiuc A, Szabo G. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells. Hepatology. 2011;54:133–44.PubMedCrossRef
30.
Zurück zum Zitat Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2004;117:561–74.PubMedCrossRef Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2004;117:561–74.PubMedCrossRef
31.
Zurück zum Zitat Yamamoto M, Yaginuma K, Tsutsui H, Sagara J, Guan X, Seki E, et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells. 2004;9:1055–67.PubMedCrossRef Yamamoto M, Yaginuma K, Tsutsui H, Sagara J, Guan X, Seki E, et al. ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules. Genes Cells. 2004;9:1055–67.PubMedCrossRef
33.
Zurück zum Zitat Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787–91.PubMedCentralPubMedCrossRef Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol. 2009;183:787–91.PubMedCentralPubMedCrossRef
34.
Zurück zum Zitat Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423–74.PubMedCrossRef Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423–74.PubMedCrossRef
36.
Zurück zum Zitat Kaplowitz N, Than TA, Shinohara M, Ji C. Endoplasmic reticulum stress and liver injury. Semin Liver Dis. 2007;27:367–77.PubMedCrossRef Kaplowitz N, Than TA, Shinohara M, Ji C. Endoplasmic reticulum stress and liver injury. Semin Liver Dis. 2007;27:367–77.PubMedCrossRef
37.
Zurück zum Zitat Ben Mosbah I, Alfany-Fernandez I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, et al. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion. Cell Death Dis. 2010;1:e52.PubMedCentralPubMedCrossRef Ben Mosbah I, Alfany-Fernandez I, Martel C, Zaouali MA, Bintanel-Morcillo M, Rimola A, et al. Endoplasmic reticulum stress inhibition protects steatotic and non-steatotic livers in partial hepatectomy under ischemia–reperfusion. Cell Death Dis. 2010;1:e52.PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004;18:3066–77.PubMedCentralPubMedCrossRef Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y, Jungreis R, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004;18:3066–77.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Sanges D, Marigo V. Cross-talk between two apoptotic pathways activated by endoplasmic reticulum stress: differential contribution of caspase-12 and AIF. Apoptosis. 2006;11:1629–41.PubMedCrossRef Sanges D, Marigo V. Cross-talk between two apoptotic pathways activated by endoplasmic reticulum stress: differential contribution of caspase-12 and AIF. Apoptosis. 2006;11:1629–41.PubMedCrossRef
40.
Zurück zum Zitat Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res. 2012;110:174–89.PubMedCentralPubMedCrossRef Kolattukudy PE, Niu J. Inflammation, endoplasmic reticulum stress, autophagy, and the monocyte chemoattractant protein-1/CCR2 pathway. Circ Res. 2012;110:174–89.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis. 2012;3:e261.PubMedCentralPubMedCrossRef Menu P, Mayor A, Zhou R, Tardivel A, Ichijo H, Mori K, et al. ER stress activates the NLRP3 inflammasome via an UPR-independent pathway. Cell Death Dis. 2012;3:e261.PubMedCentralPubMedCrossRef
42.
Zurück zum Zitat Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720–8.PubMedCentralPubMedCrossRef Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000;19:5720–8.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Semin Immunopathol. 2010;32:431–6.PubMedCrossRef Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Semin Immunopathol. 2010;32:431–6.PubMedCrossRef
45.
Zurück zum Zitat Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12:222–30.PubMedCentralPubMedCrossRef Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol. 2011;12:222–30.PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011;30:4701–11.PubMedCentralPubMedCrossRef Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J. 2011;30:4701–11.PubMedCentralPubMedCrossRef
Metadaten
Titel
Kir6.2 knockout aggravates lipopolysaccharide-induced mouse liver injury via enhancing NLRP3 inflammasome activation
verfasst von
Ren-Hong Du
Jun Tan
Nan Yan
Ling Wang
Chen Qiao
Jian-Hua Ding
Ming Lu
Gang Hu
Publikationsdatum
01.04.2014
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 4/2014
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-013-0823-0

Weitere Artikel der Ausgabe 4/2014

Journal of Gastroenterology 4/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.